Skip to content
2000
Volume 10, Issue 2
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Hepatic cancer is one of most common cause of cancer-related death. Hepato-epithelial cancers are believed to originate from the malignant transformation of liver-resident stem/progenitor cells. Liver cancer stem cells have been characterized recently and the phenotype of liver cancer stem cells has been defined as CD133+ CD44+ cancer cells. Recently, it has been also demonstrated about the relevance of targeting liver cancer stem cells, due to cancer stem cells are related to cancer metastasis. These advances no doubt to bring the new strategy in liver cancer treatment and control in this disease. This review describes the current status and progress about cancer stem cell research in liver and discuss of the implications of these studies in new liver cancer treatment strategies.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/187152010790909263
2010-02-01
2025-05-24
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/187152010790909263
Loading

  • Article Type:
    Research Article
Keyword(s): CD133; CD44; CD90; IL-6; TGF-β
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test